#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15854	16S	1529	1529	100.0	16S.l15.c17.ctg.2	2273	838.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1451	1451	C	1014	C,T	1013,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15854	16S	1529	1529	100.0	16S.l15.c17.ctg.2	2273	838.5	0	HET	.	.	.	C1450T,G,A	.	1450	1450	C	1717	1717	C	1006	C,T,G,A	766,238,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15854	16S	1529	1529	100.0	16S.l15.c17.ctg.2	2273	838.5	0	HET	.	.	.	C450T,G	.	450	450	C	717	717	C	1055	C,T,G	840,213,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26444	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4178	788.1	0	.	n	.	0	T695C	SNP	695	695	T	1330	1330	C	996	C,T,G	990,2,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26444	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4178	788.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1972	1972	A	1109	A,G,T,C	1101,3,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26444	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4178	788.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2606	2606	C	883	C,A,G	879,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26444	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4178	788.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2680	2680	A	857	A	857	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26444	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4178	788.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3232	3232	C	981	C,A	979,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2298	folP	855	855	100.0	folP.l6.c17.ctg.1	1999	142.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1292	1294	AGC	216;215;216	A;G,T;C,G	216;214,1;215,1	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5418	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3857	174.9	1	SNP	p	S91F	1	.	.	271	273	TTC	821	823	TTC	226;226;224	T,C;T,A;C	225,1;225,1;224	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5418	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3857	174.9	1	SNP	p	D95G	1	.	.	283	285	GGC	833	835	GGC	231;233;235	G;G;C	231;233;235	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5418	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3857	174.9	1	SNP	p	G95N	0	.	.	283	285	GGC	833	835	GGC	231;233;235	G;G;C	231;233;235	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1996	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1782	139.5	1	SNP	p	G45D	0	.	.	133	135	GGC	664	666	GGC	230;227;229	G,T;G;C	229,1;227;229	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1076	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1485	90.3	0	.	n	.	0	A197.	DEL	197	197	A	803	803	A	224	A	224	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5214	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3525	184.2	1	SNP	p	D86N	0	.	.	256	258	GAC	787	789	GAC	224;227;225	G,C;A,G;C,A	223,1;224,3;224,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5214	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3525	184.2	1	SNP	p	R87I	0	.	.	259	261	CGT	790	792	CGT	226;228;230	C,G;G,A;T,G	225,1;227,1;229,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5214	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3525	184.2	1	SNP	p	R87W	0	.	.	259	261	CGT	790	792	CGT	226;228;230	C,G;G,A;T,G	225,1;227,1;229,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5214	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3525	184.2	1	SNP	p	S87R	1	.	.	259	261	CGT	790	792	CGT	226;228;230	C,G;G,A;T,G	225,1;227,1;229,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5214	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3525	184.2	1	SNP	p	S88P	0	.	.	262	264	TCC	793	795	TCC	233;233;233	T,C;C,A;C,T	232,1;232,1;232,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4446	parE	1986	1986	100.0	parE.l6.c30.ctg.1	3222	171.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1884	1886	GGC	252;252;249	G,T,A;G;C	250,1,1;252;249	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4238	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2906	181.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1537	1539	GCA	232;232;235	G;C;A	232;232;235	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4238	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2906	181.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1540	1542	ATC	235;234;235	A,C;T;C	234,1;234;235	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4238	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2906	181.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1552	1554	GTG	236;237;239	G,T;T;G	235,1;237;239	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4238	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2906	181.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1552	1554	GTG	236;237;239	G,T;T;G	235,1;237;239	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4238	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2906	181.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2056	2058	ACC	243;243;242	A;C;C	243;243;242	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4238	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2906	181.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2110	2112	GCG	242;245;242	G;C,G,A;G	242;243,1,1;242	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4238	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2906	181.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2110	2112	GCG	242;245;242	G;C,G,A;G	242;243,1,1;242	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4238	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2906	181.8	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2233	2235	AGC	214;212;217	A;G;C,A	214;212;216,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4238	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2906	181.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2242	2244	GGC	226;228;228	G,T;G;C	225,1;228;228	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4238	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2906	181.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2260	2262	CCG	233;239;237	C;C;G,C	233;239;236,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5666	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3723	189.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	2015	2017	CCG	227;226;224	C;C;G	227;226;224	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2550	porA	1146	1146	99.91	porA.l6.c4.ctg.1	2269	139.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	741	741	C	215	C	215	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	304	porB1a	984	100	94.0	porB1a.l15.c4.ctg.2	182	54.9	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	69;65;63	A;C;G,A	69;65;62,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	304	porB1a	984	100	94.0	porB1a.l15.c4.ctg.2	182	54.9	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	17;17;15	C;A;A	17;17;15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	304	porB1a	984	150	93.33	porB1a.l15.c4.ctg.5	153	45.7	0	.	p	.	0	V258L	NONSYN	772	774	GTA	13	15	TTA	21;24;24	T;T;A	21;24;24	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	304	porB1a	984	150	93.33	porB1a.l15.c4.ctg.5	153	45.7	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	58	60	CAT	56;56;56	C;A;T	56;56;56	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	304	porB1a	984	150	93.33	porB1a.l15.c4.ctg.5	153	45.7	0	.	p	.	0	D274S	NONSYN	820	822	GAT	61	63	AGT	56;56;56	A;G;T	55;55;55	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	304	porB1a	984	150	93.33	porB1a.l15.c4.ctg.5	153	45.7	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	70	72	TAC	56;56;56	T;A;C,A	56;56;55,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2974	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1967	187.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	685	687	GAA	240;239;241	G;A;A	240;239;241	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2974	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1967	187.1	0	.	p	.	0	T119A	NONSYN	355	357	ACC	928	930	GCC	245;243;242	G,T,A;C,T,A;C	243,1,1;241,1,1;242	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2974	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1967	187.1	0	.	p	.	0	N134D	NONSYN	400	402	AAT	973	975	GAT	241;242;241	G;A,G;T	241;241,1;241	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2974	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1967	187.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1096	1098	TCA	276;278;276	T,G;C,G,T,A;A,C,T	275,1;274,2,1,1;273,2,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2974	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1967	187.1	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1225	1227	GTC	276;277;275	G;T,C;C	276;276,1;275	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2974	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1967	187.1	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1555	1557	GCA	255;254;251	G;C;A	255;254;251	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2974	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1967	187.1	1	SNP	p	G120K	1	.	.	358	360	AAG	931	933	AAG	242;243;242	A;A,C;G,C	242;242,1;241,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2974	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1967	187.1	1	SNP	p	D121N	0	.	.	361	363	GAC	934	936	GAC	243;243;242	G,T;A;C	242,1;243;242	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2974	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1967	187.1	1	SNP	p	A121D	1	.	.	361	363	GAC	934	936	GAC	243;243;242	G,T;A;C	242,1;243;242	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10046	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	5446	229.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1472	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1553	118.3	1	SNP	p	V57M	1	.	.	169	171	ATG	755	757	ATG	261;259;259	A;T,G;G	261;258,1;259	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
